Bioventure firms suffered insufficient number of R&D personnel

Published: 2002-09-10 06:59:00

Updated: 2002-09-10 06:59:00

Bioventure businesses have suffered from a shortage of R&D and marketing personnel with worsened financial conditions, according to a survey conducted on 600 bioventure firms in Korea by the Korea Bioventure Association in a period ranging from April 25 to the end of June, this year.

In terms ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK